MedTrace Logo

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

NCT01077440 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2014-12-10

No results posted yet for this study

Summary

RATIONALE: Studying samples of semen from cancer survivors in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This phase I research study is looking at the presence of donor-derived DNA in semen samples form cancer survivors who underwent donor stem cell transplant.

Conditions

Interventions

GENETIC

DNA analysis

DNA analysis will be performed on samples collected.

GENETIC

polymerase chain reaction

A polymerase chain reaction (PCR) assessment will be done on the samples collected.

OTHER

flow cytometry

Flow cytometry will be done on the samples collected.

OTHER

laboratory biomarker analysis

Laboratory biomarker analysis will be performed on the samples collected.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Haydar A. Frangoul, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01077440 on ClinicalTrials.gov